Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Treatment options for obstructive sleep apnea.

Patch JR.

CMAJ. 2018 Nov 12;190(45):E1340. doi: 10.1503/cmaj.70459. No abstract available.

PMID:
30420392
2.

Expanding specificity of class I restricted CD8+ T cells for viral epitopes following multiple inoculations of swine with a human adenovirus vectored foot-and-mouth disease virus (FMDV) vaccine.

Pedersen LE, Patch JR, Kenney M, Glabman RA, Nielsen M, Jungersen G, Buus S, Golde WT.

Vet Immunol Immunopathol. 2016 Nov 15;181:59-67. doi: 10.1016/j.vetimm.2016.07.012. Epub 2016 Jul 27.

PMID:
27498407
3.

Infection with foot-and-mouth disease virus (FMDV) induces a natural killer (NK) cell response in cattle that is lacking following vaccination.

Patch JR, Dar PA, Waters R, Toka FN, Barrera J, Schutta C, Kondabattula G, Golde WT.

Comp Immunol Microbiol Infect Dis. 2014 Sep;37(4):249-57. doi: 10.1016/j.cimid.2014.07.004. Epub 2014 Aug 12.

PMID:
25150134
4.

Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.

Patch JR, Kenney M, Pacheco JM, Grubman MJ, Golde WT.

Viral Immunol. 2013 Aug;26(4):239-49. doi: 10.1089/vim.2013.0011. Epub 2013 Jul 5.

5.

Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401.

Pedersen LE, Harndahl M, Nielsen M, Patch JR, Jungersen G, Buus S, Golde WT.

Anim Genet. 2013 Jun;44(3):251-8. doi: 10.1111/j.1365-2052.2012.02400.x. Epub 2012 Sep 18.

PMID:
22984928
6.

Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Patch JR, Pedersen LE, Toka FN, Moraes M, Grubman MJ, Nielsen M, Jungersen G, Buus S, Golde WT.

Clin Vaccine Immunol. 2011 Feb;18(2):280-8. doi: 10.1128/CVI.00417-10. Epub 2010 Dec 22.

7.

Mutations in classical swine fever virus NS4B affect virulence in swine.

Fernandez-Sainz I, Gladue DP, Holinka LG, O'Donnell V, Gudmundsdottir I, Prarat MV, Patch JR, Golde WT, Lu Z, Zhu J, Carrillo C, Risatti GR, Borca MV.

J Virol. 2010 Feb;84(3):1536-49. doi: 10.1128/JVI.02050-09. Epub 2009 Nov 18.

8.

The YPLGVG sequence of the Nipah virus matrix protein is required for budding.

Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, Broder CC.

Virol J. 2008 Nov 10;5:137. doi: 10.1186/1743-422X-5-137.

9.

Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.

Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, Wang LF, Dimitrov DS, Broder CC.

J Virol. 2008 Nov;82(22):11398-409. doi: 10.1128/JVI.02654-07. Epub 2008 Sep 17.

10.
11.

Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.

Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC.

J Virol. 2005 Jun;79(11):6690-702.

Supplemental Content

Loading ...
Support Center